Thanks Imp: Correct their first drug showed no efficacy but the pressure from the DMD community helped getting it commercialised Its about tIme the FDA clamped down on this practice. No point in giving DMD patients drugs that don’t really work… The DMD boys don’t have time to waste… Give Atl1102 a green light now instead of waiting 12 months… If there is a problem : Stop the dosing,. It will still be better than Sareptas drugs…
ANP Price at posting:
8.7¢ Sentiment: Buy Disclosure: Held
